Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Inga M. Antonsdottir"'
Autor:
Robert M. Chapman, Margaret N. Gardner, Rafael Klorman, Mark Mapstone, Anton P. Porsteinsson, Inga M. Antonsdottir, Lily Kamalyan
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 10, Iss 1, Pp 604-614 (2018)
Abstract Introduction Developing biomarkers that distinguish individuals with Alzheimer's disease (AD) from those with normal cognition remains a crucial goal for improving the health of older adults. We investigated adding brain spatial information
Externí odkaz:
https://doaj.org/article/4dde83175abe4f2e8320817fa849c454
Publikováno v:
Expert Opinion on Pharmacotherapy. 24:691-703
Autor:
Anton P. Porsteinsson, Margaret N. Gardner, Lily Kamalyan, Mark Mapstone, Robert M. Chapman, Inga M. Antonsdottir, Rafael Klorman
Publikováno v:
Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, Vol 10, Iss 1, Pp 604-614 (2018)
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
Introduction Developing biomarkers that distinguish individuals with Alzheimer's disease (AD) from those with normal cognition remains a crucial goal for improving the health of older adults. We investigated adding brain spatial information to tempor
Publikováno v:
Expert Opinion on Pharmacotherapy. 18:611-620
Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are associated with significant negative outcomes for patients and their caregivers. Agitation, one of the most distressing NPS, lacks safe and effective long term interventions. Nonpharmaco
Publikováno v:
Expert Opinion on Pharmacotherapy. 16:1649-1656
Neuropsychiatric symptoms (NPS) in Alzheimer's disease (AD) are associated with significant negative outcomes for patients and their caregivers. Agitation, one of the most distressing NPS, lacks well-established long-term interventions that are both
Publikováno v:
The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry. 24(11)
Autor:
Haley M. Dupree, Anton P. Porsteinsson, Rafael Klorman, Mark Mapstone, Inga M. Antonsdottir, Lily Kamalyan, Robert M. Chapman, Margaret N. Gardner
Publikováno v:
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, vol 127, iss 6
Objective To determine how aging and dementia affect the brain’s initial storing of task-relevant and irrelevant information in short-term memory. Methods We used brain Event-Related Potentials (ERPs) to measure short-term memory storage (ERP compo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1328483d8f9d30494bf6e560f0cf5e5
https://escholarship.org/uc/item/09g1x86n
https://escholarship.org/uc/item/09g1x86n
Publikováno v:
Expert Review of Neurotherapeutics. 14:969-971
Neuropsychiatric symptoms (NPS) are a major concern in the treatment of Alzheimer's disease. Historically, NPS are difficult to treat effectively due to a high side-effect burden associated with commonly used medications, such as atypical antipsychot
Brain event-related potentials (ERPs) offer a quantitative link between neurophysiological activity and cognitive performance. ERPs were measured while young adults performed a task that required storing a relevant stimulus in short-term memory. Usin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b807008c3bfc8a121425b4a565c58f32
https://europepmc.org/articles/PMC4524323/
https://europepmc.org/articles/PMC4524323/
Publikováno v:
American Journal of Psychiatry. 172:410-411
Alzheimer’s disease is characterized by progressive cognitive and functional decline. There are extensive and reciprocal neuronal connections between the epicenters of emotions and cognition (1). Thus, it isnot surprising that thenatural courseof A